Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2012 Feb;10(2):162-209.
doi: 10.6004/jnccn.2012.0019.

Senior adult oncology

Arti Hurria  1 , Ilene S Browner, Harvey Jay Cohen, Crystal S Denlinger, Mollie deShazo, Martine Extermann, Apar Kishor P Ganti, Jimmie C Holland, Holly M Holmes, Mohana B Karlekar, Nancy L Keating, June McKoy, Bruno C Medeiros, Ewa Mrozek, Tracey O'Connor, Stephen H Petersdorf, Hope S Rugo, Rebecca A Silliman, William P Tew, Louise C Walter, Alva B Weir 3rd, Tanya Wildes
Affiliations
Practice Guideline

Senior adult oncology

Arti Hurria et al. J Natl Compr Canc Netw. 2012 Feb.
No abstract available

PubMed Disclaimer

Figures

None
aSee histograms for age-specific life expectancy (page 167). bSessums LL, Zembrzuska H, Jackson JL. Does this patient have medical decision-making capacity? JAMA 2011;306:420-427. cHarrington SE, Smith TJ. The role of chemotherapy at the end of life: when is enough, enough? JAMA 2008;299:2667-2678.
None
dSee Comprehensive Geriatric Assessment (pages 176-177). eThe panel recommends calculation of creatinine clearance to assess renal function for all patients.
None
*For the most recent version of these guidelines, visit the NCCN Web site at www.NCCN.org. fMonitor the patient’s functional status, comorbidities, social circumstances, pain, nutritional status, and distress. gPiccart-Gebhart M, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659-1672. hRomond E, Perez E, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;35:1673-1684.
None
Reprinted and adapted with permission from Walter LC, Covinsky KE. Cancer screening in elderly patients. JAMA 2001;285:2750-2756.
See this image and copyright information in PMC

References

    1. Joudi FN, Smith BJ, O’Donnell MA, Konety BR. The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy. J Urol. 2006;175:1634–1639. - PubMed
    1. Herr HW. Age and outcome of superficial bladder cancer treated with bacille Calmette-Guerin therapy. Urology. 2007;70:65–68. - PubMed
    1. Chamie K, Hu B, Devere White RW, Ellison LM. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int. 2008;102:284–290. - PubMed
    1. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–866. - PubMed
    1. Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005;293:1073–1081. - PubMed

Publication types

LinkOut - more resources